Oppenheimer & Co’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $540K | Sell |
2,555
-10,809
| -81% | -$2.33M | 0.01% | 1162 |
|
|
2025
Q4 | $2.75M | Buy |
13,364
+1,784
| +15% | +$336K | 0.04% | 454 |
|
|
2025
Q3 | $1.82M | Sell |
11,580
-1,131
| -9% | -$175K | 0.02% | 639 |
|
|
2025
Q2 | $2.14M | Sell |
12,711
-562
| -4% | -$83.4K | 0.03% | 554 |
|
|
2025
Q1 | $1.83M | Buy |
13,273
+11,020
| +489% | +$1.4M | 0.03% | 572 |
|
|
2024
Q4 | $266K | Buy |
2,253
+2
| +0.1% | +$233 | ﹤0.01% | 1329 |
|
|
2024
Q3 | $249K | Sell |
2,251
-749
| -25% | -$78.3K | ﹤0.01% | 1323 |
|
|
2024
Q2 | $295K | Sell |
3,000
-9,871
| -77% | -$1.01M | ﹤0.01% | 1197 |
|
|
2024
Q1 | $1.44M | Sell |
12,871
-3,760
| -23% | -$406K | 0.02% | 617 |
|
|
2023
Q4 | $1.68M | Buy |
16,631
+747
| +5% | +$74.1K | 0.03% | 548 |
|
|
2023
Q3 | $1.38M | Sell |
15,884
-901
| -5% | -$81.4K | 0.03% | 570 |
|
|
2023
Q2 | $1.59M | Sell |
16,785
-1
| -0% | -$84 | 0.03% | 536 |
|
|
2023
Q1 | $1.27M | Sell |
16,786
-172
| -1% | -$13K | 0.03% | 601 |
|
|
2022
Q4 | $1.3M | Sell |
16,958
-1,594
| -9% | -$121K | 0.03% | 571 |
|
|
2022
Q3 | $1.24M | Sell |
18,552
-514
| -3% | -$32.6K | 0.03% | 586 |
|
|
2022
Q2 | $996K | Buy |
19,066
+15,447
| +427% | +$878K | 0.02% | 684 |
|
|
2022
Q1 | $205K | Sell |
3,619
-914
| -20% | -$49K | ﹤0.01% | 1342 |
|
|
2021
Q4 | $234K | Buy |
+4,533
| New | +$222K | ﹤0.01% | 1333 |
|
|
2021
Q3 | – | Sell |
-5,638
| Closed | -$322K | – | 1497 |
|
|
2021
Q2 | $322K | Sell |
5,638
-2,561
| -31% | -$150K | 0.01% | 1205 |
|
|
2021
Q1 | $498K | Buy |
8,199
+21
| +0.3% | +$1.16K | 0.01% | 964 |
|
|
2020
Q4 | $438K | Buy |
8,178
+107
| +1% | +$5.55K | 0.01% | 949 |
|
|
2020
Q3 | $379K | Buy |
8,071
+1,488
| +23% | +$76.4K | 0.01% | 903 |
|
|
2020
Q2 | $344K | Sell |
6,583
-13,800
| -68% | -$711K | 0.01% | 922 |
|
|
2020
Q1 | $977K | Buy |
20,383
+13,890
| +214% | +$721K | 0.03% | 528 |
|
|
2019
Q4 | $328K | Buy |
+6,493
| New | +$335K | 0.01% | 988 |
|
|
2019
Q3 | – | Sell |
-14,595
| Closed | -$688K | – | 1272 |
|
|
2019
Q2 | $688K | Buy |
14,595
+282
| +2% | +$13K | 0.02% | 710 |
|
|
2019
Q1 | $689K | Sell |
14,313
-1,302
| -8% | -$65.2K | 0.02% | 699 |
|
|
2018
Q4 | $696K | Buy |
15,615
+113
| +0.7% | +$5.89K | 0.02% | 632 |
|
|
2018
Q3 | $837K | Sell |
15,502
-9,464
| -38% | -$484K | 0.02% | 655 |
|
|
2018
Q2 | $1.22M | Buy |
24,966
+5,538
| +29% | +$314K | 0.03% | 522 |
|
|
2018
Q1 | $1.22M | Buy |
+19,428
| New | +$1.33M | 0.03% | 539 |
|
|
2017
Q2 | – | Sell |
-4,939
| Closed | -$403K | – | 1308 |
|
|
2017
Q1 | $403K | Sell |
4,939
-887
| -15% | -$69.8K | 0.01% | 883 |
|
|
2016
Q4 | $420K | Sell |
5,826
-102
| -2% | -$7.37K | 0.01% | 863 |
|
|
2016
Q3 | $461K | Buy |
5,928
+1,635
| +38% | +$132K | 0.01% | 839 |
|
|
2016
Q2 | $335K | Sell |
4,293
-712
| -14% | -$56.8K | 0.01% | 929 |
|
|
2016
Q1 | $410K | Sell |
5,005
-36
| -0.7% | -$2.93K | 0.01% | 823 |
|
|
2015
Q4 | $450K | Buy |
5,041
+923
| +22% | +$78.4K | 0.01% | 803 |
|
|
2015
Q3 | $316K | Sell |
4,118
-193
| -4% | -$16.1K | 0.01% | 977 |
|
|
2015
Q2 | $361K | Buy |
4,311
+1,887
| +78% | +$167K | 0.01% | 1022 |
|
|
2015
Q1 | $219K | Buy |
+2,424
| New | +$209K | 0.01% | 1256 |
|
|
2014
Q4 | – | Sell |
-3,664
| Closed | -$275K | – | 1402 |
|
|
2014
Q3 | $275K | Buy |
3,664
+23
| +0.6% | +$1.67K | 0.01% | 1107 |
|
|
2014
Q2 | $250K | Buy |
3,641
+501
| +16% | +$34.1K | 0.01% | 1148 |
|
|
2014
Q1 | $220K | Buy |
+3,140
| New | +$218K | 0.01% | 1190 |
|
Other funds holding CAH
VCM
VPM
Oppenheimer & Co's CAH Position: Q1 2026 in Review
Oppenheimer & Co reduced its Cardinal Health (CAH) stake by 81% in Q1 2026, selling an estimated $2.33M and leaving 2,555 shares worth $540K. The position accounts for 0.01% of the portfolio, ranked #1162.
Oppenheimer & Co first reported a position in CAH in Q1 2014 and has held it in 43 quarters since. The position peaked at $2.75M in Q4 2025. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Oppenheimer & Co held 2,555 shares of Cardinal Health worth $540K as of Q1 2026.
- Oppenheimer & Co sold 10,809 Cardinal Health shares in Q1 2026, an estimated $2.33M.
- Cardinal Health made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1162 holding.
- Oppenheimer & Co first reported a position in Cardinal Health in Q1 2014 and has held it in 43 quarters since.
- Oppenheimer & Co's Cardinal Health position peaked at $2.75M in Q4 2025.
- 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.